Therapeutic Dilemma of Natural Watchman: Congenital Absence of the Left Atrial Appendage

Q: What is the clinical evidence from this study?

Study design: Case Report. Population: Congenital absence of the left atrial appendage and atrial fibrillation (n=1). Intervention: Congenital absence of the left atrial appendage.

Q: What does this research mean for the field?

Congenital absence of the left atrial appendage in patients with atrial fibrillation introduces a therapeutic dilemma regarding the necessity of systemic anticoagulation. Novelty: ClaimNovelty.INCREMENTAL. Consensus alignment: ConsensusAlignment.NEUTRAL.

Phoo Pwint Nandar; Asim Kichloo; Thein Aung; Kevin D. Kravitz

doi:10.1155/2018/7573425

July 25, 2018Case Reports in CardiologyOpen Access

Therapeutic Dilemma of Natural Watchman: Congenital Absence of the Left Atrial Appendage

View Full Paper

Ask AI

Bookmark

Share

Key result

Rare congenital LAA absence in AF highlights the therapeutic dilemma of anticoagulation.

n=1

Figures

Why the study?

Congenital absence of the left atrial appendage is a rare cardiac anomaly with unclear implications for anticoagulation management in atrial fibrillation patients.

Key Points

To evaluate the necessity and clinical role of anticoagulation therapy in a patient with atrial fibrillation presenting with congenital absence of the left atrial appendage.
Clinical evaluation and management analysis of a 77-year-old female patient with atrial fibrillation found to have congenital absence of the left atrial appendage.
Review of theoretical mechanisms and scientific evidence regarding left atrial thromboembolism risk in the absence of the appendage.
Congenital absence of the left atrial appendage functions as an anatomical equivalent to surgical or percutaneous appendage occlusion.
Systemic thromboembolic risk in atrial fibrillation originates primarily, but not exclusively, within the appendage, creating uncertainty about whether to omit oral anticoagulation.

Study Design

Type

Case Report (n=1)

Structured PICO

P

Population

A 77-year-old female patient with atrial fibrillation and congenital absence of the left atrial appendage.

E

Exposure

Anticoagulation (discussion of its role)

Ask about this paper

Answers are grounded in this paper and cite their sources.

Implication

This case report highlights the therapeutic dilemma regarding the necessity of anticoagulation in patients with atrial fibrillation who have a congenital absence of the left atrial appendage.

Abstract

Congenital absence of the left atrial appendage is a rare congenital cardiac anomaly which is usually an incidental finding. We present a rare case of congenital absence of the left atrial appendage in a 77-year-old female patient with atrial fibrillation, and we will discuss the role of anticoagulation in the patient with congenital absence of the left atrial appendage based on the scientific data and theoretic background.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Nandar et al. (2018) conducted a case report in Congenital absence of the left atrial appendage and atrial fibrillation (n=1). Congenital absence of the left atrial appendage was evaluated. A rare case of congenital absence of the left atrial appendage in a 77-year-old female with atrial fibrillation highlights the therapeutic dilemma regarding the role of anticoagulation.

synapsesocial.com/papers/6aaf28c13a1726cc7f3984cf https://doi.org/10.1155/2018/7573425

View Full Paper

Ask AI

Bookmark

Share

Therapeutic Dilemma of Natural Watchman: Congenital Absence of the Left Atrial Appendage

Figures

Key Points

Study Design

Structured PICO

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Therapeutic Dilemma of Natural Watchman: Congenital Absence of the Left Atrial Appendage

Figures

Key Points

Study Design

Structured PICO

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading